Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$423K Buy
+2,014
New +$447K 0.04% 423
2026
Q1
– Sell
-12,386
Closed -$3.14M – 624
2025
Q4
$3.14M Buy
12,386
+9,120
+279% +$2.29M 0.44% 26
2025
Q3
$808K Sell
3,266
-13,343
-80% -$3.19M 0.12% 308
2025
Q2
$3.99M Buy
16,609
+13,580
+448% +$3.16M 0.59% 24
2025
Q1
$687K Sell
3,029
-5,356
-64% -$1.18M 0.14% 249
2024
Q4
$1.72M Buy
8,385
+7,175
+593% +$1.57M 0.51% 37
2024
Q3
$293K Buy
+1,210
New +$283K 0.1% 336

Other funds holding STE

Oak Thistle's STE Position: Q3 2026 in Review

Oak Thistle opened a new position in Steris (STE) in Q3 2026: 2,014 shares worth $423K. The stake represents 0.04% of the portfolio and ranks #423 among its holdings. This is a return to the name: Oak Thistle previously reported a position in STE as recently as Q4 2025.

Oak Thistle first reported a position in STE in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.99M in Q2 2025. 683 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • Oak Thistle held 2,014 shares of Steris worth $423K as of Q3 2026.
  • Steris was a new Oak Thistle position in Q3 2026.
  • Steris made up 0.04% of Oak Thistle's portfolio in Q3 2026, its #423 holding.
  • Oak Thistle first reported a position in Steris in Q3 2024 and has held it in 7 quarters since.
  • Oak Thistle's Steris position peaked at $3.99M in Q2 2025.
  • 683 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.